Cholamandalam Investment and Finance Company Limited

NSE:CHOLAFIN.NS

1596.3 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 194,198.773,575.658,641.850,207.841,315.535,124.634,490.75528,219.58623,766.08619,828.03116,591.00813,379.2549,036.31112,222.4119,564.60511,455.4059,460.9124,376.4652,449.1322,309.062
Cost of Revenue 94,288.11,275.81,177.71,0521,128.6587.6538.26,348.8145,130.167000-8,756.6430000000
Gross Profit 99,910.672,299.857,464.149,155.840,186.934,53733,952.55521,870.77218,635.91919,828.03116,591.00813,379.25417,792.95412,222.4119,564.60511,455.4059,460.9124,376.4652,449.1322,309.062
Gross Profit Ratio 0.5140.9830.980.9790.9730.9830.9840.7750.7841111.9691111111
Reseach & Development Expenses 0000000000001.3020000012.2150
General & Administrative Expenses 1,666.31,432.51,213.8437.6469.6479.1706.593539.497406.324414.882359.142393.942249.3420000053.48340.329
Selling & Marketing Expenses 240.6151129.8126.7145.416086.32877.47754.8383.32512.67955.12174.8110000023.23526.567
SG&A 24,7861,583.51,343.6564.3615639.1792.921616.974461.162418.207371.821449.063324.1530000076.71866.896
Other Expenses -40,681.5-24,997.419,422.115,938.215,843.541.78624.6432.2413.9967.28113.055300-5,921.511-5,038.4970.012-3,788.473-1,889.507890.359916.234
Operating Expenses 40,681.528,932.620,765.716,502.516,458.513,897.116,167.86613,985.9410,703.3699,913.9598,231.827,624.2355,664.2882,601.8632,273.943,419.2123,594.4651,672.554979.292983.13
Operating Income 59,229.136,152.529,010.420,446.415,881.954,069.635,375.57729,836.76427,167.79223,985.83421,703.50216,791.90912,598.5229,620.5487,290.6658,036.1935,866.4472,703.9111,469.841,325.932
Operating Income Ratio 0.3050.4910.4950.4070.3841.5391.0261.0571.1431.211.3081.2551.3940.7870.7620.7020.620.6180.60.574
Total Other Income Expenses Net -13,176-124.811.827.3-3.9-35,754.3-20,537.942-18,762.444-18,373.294-17,323.587-16,158.72-12,269.923-9,705.311-8,393.135-6,592.461-8,513.649-5,084.742-2,248.457-992.405-838.54
Income Before Tax 46,053.136,027.729,07620,47915,882.218,315.314,837.63511,074.328,794.4986,662.2475,544.7824,521.9862,893.2111,227.413698.204-477.456781.705455.454477.435487.392
Income Before Tax Ratio 0.2370.490.4960.4080.3840.5210.430.3920.370.3360.3340.3380.320.10.073-0.0420.0830.1040.1950.211
Income Tax Expense 11,945.79,379.27,487.15,265.15,340.86,345.95,099.5643,895.0713,048.0362,220.8851,861.9651,442.8841,203.308381.568170.532289.301308.374181.603121.931179.498
Net Income 34,200.626,648.521,535.115,208.610,537.211,980.69,754.2377,194.2965,746.7944,441.3623,682.8173,079.1021,689.903845.845527.672-188.155473.331273.851355.504307.843
Net Income Ratio 0.1760.3620.3670.3030.2550.3410.2830.2550.2420.2240.2220.230.1870.0690.055-0.0160.050.0630.1450.133
EPS 41.1732.4226.2418.5513.3915.3312.489.217.626.195.154.62.821.551.59-0.622.051.351.871.69
EPS Diluted 41.0632.3826.1918.5213.3715.3112.479.217.616.125.144.592.821.551.59-0.61.951.351.871.69
EBITDA 61,209.7-124.811.827.3-3.954,639.535,884.14830,226.92527,385.23524,286.85621,949.91317,007.63311,650.1121,327.89870.417368.016968.606528.9771,310.7941,280.097
EBITDA Ratio 0.315-0.00200.001-01.5561.041.0711.1521.2251.3231.2711.2890.1090.0910.0320.1020.1210.5350.554